Fig. 7From: Over-expression of SRD5A3 and its prognostic significance in breast cancerGenetic alteration and mutation analyses. A The alteration frequency of SRD5A3, DOLK, SRD5A1, and HSD17B3 in breast cancer. B Specific alteration percentage of SRD5A3, DOLK, SRD5A1, and HSD17B3 in breast cancer. C SRD5A3 mutation site in breast cancerBack to article page